AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,480,106 | +89.6% | 3,052,725 | +52.2% | 0.00% | +100.0% |
Q2 2023 | $1,835,452 | +359088.3% | 2,005,958 | +120.2% | 0.00% | – |
Q1 2023 | $511 | -34.1% | 910,958 | -32.1% | 0.00% | – |
Q4 2022 | $775 | -99.9% | 1,342,422 | -61.4% | 0.00% | -100.0% |
Q3 2022 | $1,101,000 | -41.8% | 3,480,858 | -35.0% | 0.00% | 0.0% |
Q2 2022 | $1,891,000 | -23.3% | 5,354,175 | +55.9% | 0.00% | 0.0% |
Q1 2022 | $2,465,000 | -43.3% | 3,433,614 | +78.5% | 0.00% | -50.0% |
Q4 2021 | $4,348,000 | +214.4% | 1,923,834 | +427.1% | 0.00% | +100.0% |
Q2 2021 | $1,383,000 | -72.7% | 364,954 | -75.6% | 0.00% | -66.7% |
Q1 2021 | $5,072,000 | -28.9% | 1,498,293 | -41.2% | 0.00% | -40.0% |
Q4 2020 | $7,130,000 | +28.7% | 2,546,507 | +15.4% | 0.01% | -28.6% |
Q3 2020 | $5,540,000 | -15.0% | 2,207,278 | +156.6% | 0.01% | -53.3% |
Q1 2020 | $6,520,000 | +53.7% | 860,215 | +28.2% | 0.02% | +200.0% |
Q4 2019 | $4,241,000 | +2132.1% | 671,058 | +1279.8% | 0.01% | – |
Q3 2019 | $190,000 | -77.7% | 48,634 | -72.4% | 0.00% | -100.0% |
Q2 2019 | $852,000 | +197.9% | 176,135 | +404.3% | 0.00% | – |
Q1 2019 | $286,000 | -78.2% | 34,925 | -85.3% | 0.00% | -100.0% |
Q4 2018 | $1,314,000 | -42.2% | 237,527 | -7.7% | 0.00% | -33.3% |
Q3 2018 | $2,273,000 | -41.7% | 257,452 | -34.2% | 0.00% | -40.0% |
Q2 2018 | $3,902,000 | -37.8% | 390,970 | -40.6% | 0.01% | -37.5% |
Q1 2018 | $6,271,000 | -58.8% | 658,022 | -35.8% | 0.01% | -61.9% |
Q4 2017 | $15,234,000 | -1.2% | 1,024,492 | +30.7% | 0.02% | -8.7% |
Q3 2017 | $15,417,000 | +82.8% | 783,800 | +33.5% | 0.02% | +53.3% |
Q2 2017 | $8,434,000 | +113.0% | 586,914 | +36.4% | 0.02% | +114.3% |
Q1 2017 | $3,959,000 | +22.3% | 430,314 | +38.4% | 0.01% | 0.0% |
Q4 2016 | $3,236,000 | +982.3% | 310,888 | +842.1% | 0.01% | +600.0% |
Q3 2016 | $299,000 | -26.2% | 33,001 | -39.1% | 0.00% | 0.0% |
Q2 2016 | $405,000 | -88.9% | 54,183 | -80.8% | 0.00% | -87.5% |
Q4 2015 | $3,650,000 | +78.1% | 282,541 | +33.2% | 0.01% | +100.0% |
Q3 2015 | $2,049,000 | +650.5% | 212,086 | +700.3% | 0.00% | +300.0% |
Q2 2015 | $273,000 | +20.8% | 26,500 | +30.4% | 0.00% | – |
Q1 2015 | $226,000 | -83.1% | 20,328 | -82.3% | 0.00% | -100.0% |
Q4 2014 | $1,339,000 | +34.3% | 115,008 | +155.2% | 0.00% | 0.0% |
Q3 2014 | $997,000 | – | 45,067 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |